Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Gunnar Tydén"'
Publikováno v:
Transplantation. 100:203-209
Outcome after renal transplantation depends on patient compliance and adherence for early detection of complications and identification of intervention opportunities. Compliance describes the degree to which patients follow medical advice and take th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13400159fb3990ec0027bc2fc0571dd8
https://doi.org/10.1097/tp.0000000000000971
https://doi.org/10.1097/tp.0000000000000971
Publikováno v:
Human Immunology. 74:1437-1444
The presence of human leukocyte antigen (HLA) and non-HLA antibodies (Abs) in kidney transplant recipients is associated with graft rejections. This study reports the results of an endothelial precursor cell crossmatch (EPCXM) test for detection of n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe6c32b781161f687b701ea10249bec
https://doi.org/10.1016/j.humimm.2013.06.005
https://doi.org/10.1016/j.humimm.2013.06.005
Autor:
J. Sandberg, Maria Herthelius, Stella Edström Halling, Ulla B. Berg, Rafael T. Krmar, Gianni Celsi, Kajsa Åsling-Monemi, Gunnar Tydén
Publikováno v:
Pediatric Nephrology. 27:145-150
There are still concerns about renal transplantation in small children. The aim of this study was to identify prenatal data, underlying diseases, patient and graft survival, graft function and growth in young renal transplant recipients at our center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c601c7775d74f0c76fed2f19043eebe4
https://doi.org/10.1007/s00467-011-1962-2
https://doi.org/10.1007/s00467-011-1962-2
Publikováno v:
Nephrology Dialysis Transplantation. 26:2394-2400
Background. As antigen-specific immunoadsorption (IA) using the Glycosorb-ABO columns is becoming increasingly popular in ABO-incompatible (ABOi) transplantation, in this study, we retrospectively investigated the efficacy of Glycosorb-ABO IA in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1de185e2025d51c87fa10ce40bdb59c
https://doi.org/10.1093/ndt/gfr237
https://doi.org/10.1093/ndt/gfr237
Publikováno v:
Transfusion and Apheresis Science. 43:231-235
As the demand for kidney transplantation is constantly growing methods to expand the donor pool have become increasingly important. ABO-incompatibility has hitherto been regarded as an absolute contraindication to living donor donation. However, as A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9904411243051cb281752f0fdc7ae714
https://doi.org/10.1016/j.transci.2010.07.016
https://doi.org/10.1016/j.transci.2010.07.016
Autor:
Jonas Wadström, Markus Gäbel, Gunnar Tydén, Persson Nh, Jan Tollemar, Lars Mjörnstedt, Henrik Ekberg, Helena Genberg, Gunnar Tufveson
Publikováno v:
Transplantation. 87:1325-1329
We performed a prospective, double blind, randomized, placebo-controlled multicenter study on the efficacy and safety of rituximab as induction therapy, together with tacrolimus, mycophenolate mofetil, and steroids. The primary endpoint was defined a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b1b68ee3bd9e39f66dc397bb8cb972
https://doi.org/10.1097/tp.0b013e3181a235fd
https://doi.org/10.1097/tp.0b013e3181a235fd
Autor:
Claudia Sommerer, Paul Keown, Yann Le Meur, Gunnar Tydén, Teun van Gelder, Michael Oellerich, Klemens Budde, Anders Hartmann, Aleksander Lõhmus, Dirk Kuypers, Johan W. de Fijter, Burkhard Tönshoff, Helio Tedesco Silva, Richard D. Mamelok, David W. Holt, Scott B. Campbell
Publikováno v:
Transplantation, 86(8), 1043-1051. Lippincott Williams & Wilkins
BACKGROUND.: Fixed-dose mycophenolate mofetil (MMF) reduces the incidence of acute rejection after solid organ transplantation. The Fixed-Dose Concentration Controlled trial assessed the feasibility and potential benefit of therapeutic drug monitorin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893b25eb25a1439362d2a68c44a78604
https://doi.org/10.1097/TP.0b013e318186f98a
https://doi.org/10.1097/TP.0b013e318186f98a
Publikováno v:
Transplantation. 84:S44-S47
ABO-incompatible (ABOi) kidney transplantation has gained a renewed interest during the past years. In 2001, a protocol for ABOi kidney transplantation based on antigen-specific immunoadsorption and rituximab was introduced at our center. In this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95efc9095737050bccf8ce337dc96c3
https://doi.org/10.1097/01.tp.0000296031.41424.f8
https://doi.org/10.1097/01.tp.0000296031.41424.f8
Publikováno v:
American Journal of Transplantation. 6:2418-2428
The anti-CD20 antibody rituximab has recently gained interest as a B-cell depleting agent in renal transplantation. However, little is known about the pharmacodynamics of rituximab in renal transplant recipients. We have therefore studied the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b60d068b67000ca25a973b052be8c9
https://doi.org/10.1111/j.1600-6143.2006.01497.x
https://doi.org/10.1111/j.1600-6143.2006.01497.x
Autor:
Inge B. Brekke, Ryszard Grenda, Gisela Offner, Gunnar Tydén, Egon Balzar, Guido Filler, Mary McGraw, Styrbjörn Friman, Martin Griebel, David Hughes, Nicholas J. A. Webb, David V. Milford, Alan R. Watson, Karel Vondrak, Jutta Gellermann, Richard Trompeter
Publikováno v:
Pediatric Transplantation. 9:498-503
This study was undertaken to compare the efficacy and safety of tacrolimus (Tac) with cyclosporin microemulsion (CyA) in pediatric renal recipients. A 6-month, randomized, prospective, open, parallel group study with an open extension phase was condu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aefd1a5c575913160b2f6896ebaf8ff1
https://doi.org/10.1111/j.1399-3046.2005.00334.x
https://doi.org/10.1111/j.1399-3046.2005.00334.x